Ebola in DR Congo: WHO allocates 70,000 Ervebo doses and keeps the international emergency in force
The World Health Organization is allocating 70,000 doses of the Ervebo vaccine to the Democratic Republic of the Congo and maintaining the public health emergency of international concern. Twenty thousand doses are reserved for a phase 3 clinical trial against the Bundibugyo strain. Rwanda and neighbouring countries are tightening border screening.
